These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 15501619)

  • 1. Diabetes is a vascular disease: the role of endothelial dysfunction in pathophysiology of cardiovascular disease in diabetes.
    Deedwania PC
    Cardiol Clin; 2004 Nov; 22(4):505-9, v. PubMed ID: 15501619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance, metabolic syndrome and endothelial dysfunction.
    Bigazzi R; Bianchi S
    J Nephrol; 2007; 20(1):10-4. PubMed ID: 17347967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease, metabolic syndrome and erectile dysfunction.
    Müller A; Mulhall JP
    Curr Opin Urol; 2006 Nov; 16(6):435-43. PubMed ID: 17053524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
    Cersosimo E; DeFronzo RA
    Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endothelial dysfunction in diabetes mellitus.
    Pănuş C; Moţa M; Vladu D; Vanghelie L; Răducanu CL
    Rom J Intern Med; 2003; 41(1):27-33. PubMed ID: 15529582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial and erectile dysfunction, diabetes mellitus, and the metabolic syndrome: common pathways and treatments?
    Fonseca V; Jawa A
    Am J Cardiol; 2005 Dec; 96(12B):13M-18M. PubMed ID: 16387560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial dysfunction in obesity: etiological role in atherosclerosis.
    Meyers MR; Gokce N
    Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):365-9. PubMed ID: 17940464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance and the endothelium.
    Hsueh WA; Lyon CJ; Quiñones MJ
    Am J Med; 2004 Jul; 117(2):109-17. PubMed ID: 15234647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endothelial function and the microcirculation in diabetes mellitus].
    Arosio E; Minuz P; Prior M
    Ann Ital Med Int; 1999; 14(2):106-13. PubMed ID: 10399372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why does diabetes mellitus increase the risk of cardiovascular disease?
    Shahab A
    Acta Med Indones; 2006; 38(1):33-41. PubMed ID: 16479030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes.
    Rask-Madsen C; King GL
    Nat Clin Pract Endocrinol Metab; 2007 Jan; 3(1):46-56. PubMed ID: 17179929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management.
    Tziomalos K; Athyros VG; Karagiannis A; Mikhailidis DP
    Nutr Metab Cardiovasc Dis; 2010 Feb; 20(2):140-6. PubMed ID: 19833491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of insulin resistance on endothelial progenitor cells and vascular repair.
    Cubbon RM; Kahn MB; Wheatcroft SB
    Clin Sci (Lond); 2009 Aug; 117(5):173-90. PubMed ID: 19630751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms for vascular injury in the metabolic syndrome.
    Yamagishi S; Nakamura K; Jinnouchi Y; Takenaka K; Imaizumi T
    Drugs Exp Clin Res; 2005; 31(3):123-9. PubMed ID: 16033251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endothelial dysfunction: pathophysiology, diagnosis and prognosis].
    Münzel T
    Dtsch Med Wochenschr; 2008 Nov; 133(47):2465-70. PubMed ID: 19006047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial dysfunction in insulin resistance and type 2 diabetes.
    Jansson PA
    J Intern Med; 2007 Aug; 262(2):173-83. PubMed ID: 17645585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of hypertension in the cardiometabolic syndrome.
    Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G
    J Hypertens; 2009 Mar; 27(3):441-51. PubMed ID: 19262221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiazolidinediones-improving endothelial function and potential long-term benefits on cardiovascular disease in subjects with type 2 diabetes.
    Dandona P; Ghanim H; Chaudhuri A; Mohanty P
    J Diabetes Complications; 2008; 22(1):62-75. PubMed ID: 18191079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial dysfunction in metabolic syndrome.
    Cozma A; Orăşan O; Sâmpelean D; Fodor A; Vlad C; Negrean V; Rednic N; Zdrenghea D
    Rom J Intern Med; 2009; 47(2):133-40. PubMed ID: 20067163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.